Investigate / reported ownership
BDX
Becton Dickinson And CO
9 tracked reported owners · snapshot updated 2026-10-04. Delayed disclosures, not live holdings or an investment recommendation.
Who reports owning BDX?
Select a manager to inspect their portfolio. Reports may cover different quarters; portfolio weights describe disclosed long 13F holdings, not total economic exposure.
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | First Eagle Investment Management | 3.4% | 23q | $2.09B | 13,815,335 |
| 2 | Greenhaven Associates | 9.9% | — 1q | $860M | 5,681,708 |
| 3 | Bill Nygren | 0.5% | 7q | $356M | 2,350,963 |
| 4 | First Pacific Advisors | 4.0% | 4q | $319M | 2,110,794 |
| 5 | Joel Greenblatt | <0.1% | 38q | $18M | 118,843 |
Go beyond ownership.
BD develops, makes and sells medical supplies, devices and related products used by healthcare institutions, physicians, laboratories, the pharmaceutical industry and the general public.
Question to investigate: After the Waters spin-off, can the remaining BD segments execute the stated compete, innovate and deliver strategy despite tariff, supply chain and China procurement pressures?
Company research reviewed 2026-10-02; a dated source-linked starting point, not the investors’ stated reasons.
Understand the business and investment case →Filing dates and original SEC sources
- First Eagle Investment Management · 2026Q2 · filed 2026-08-24 ↗
- Greenhaven Associates · 2026Q2 · filed 2026-07-28 ↗
- Bill Nygren · 2026Q2 · filed 2026-08-14 ↗
- First Pacific Advisors · 2026Q2 · filed 2026-08-14 ↗
- Joel Greenblatt · 2026Q2 · filed 2026-09-02 ↗
- Robert Olstein · 2026Q1 · filed 2026-04-21 ↗
- Hillman Capital Management · 2026Q2 · filed 2026-08-14 ↗
- Mairs & Power Funds · 2026Q2 · filed 2026-08-14 ↗
- Jensen Investment Management · 2026Q2 · filed 2026-08-07 ↗
Reported position changes
Net disclosed share changes—not individual trades or execution dates. NEW has no prior-position percentage comparison; EXIT weight refers to the previous report.
| Manager | Move | % Port. | Δ Shares | Value | Filed |
|---|---|---|---|---|---|
| Greenhaven Associates | NEW | 9.9% | New position | $860M | Jul 28, 2026 |
Keep your next step small.
Save the company and inspect its evidence. Recording a private view is optional and requires a separate, explicit save.
Record my own view →Optional email follow
Latticework Follow
Follow BDX
Email me only when a reviewed weekly edition contains a material new decision about BDX: a new position, exit, or a large share-count change that also clears the size threshold. There may be quiet weeks.
Confirm by email. Manage or stop follows in one click. See our privacy notice.
Long US 13F disclosures omit shorts and can be amended. CUSIP 075887109. No current price, valuation or manager motive is inferred.